About Veszprém Megyei Tüdőgyógyintézet
Clinical Trials at Veszprém Megyei Tüdőgyógyintézet
During the past decade, Veszprém Megyei Tüdőgyógyintézet conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 12 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Veszprém Megyei Tüdőgyógyintézet" #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials
sponsored, "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Janssen Research & Development, LLC"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Veszprém Megyei Tüdőgyógyintézet"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Veszprém Megyei Tüdőgyógyintézet
According to Clinical.Site data, the most researched conditions in "Veszprém Megyei Tüdőgyógyintézet" are
"Carcinoma, Non-Small-Cell Lung" (7 trials), "Non-Small Cell Lung Cancer" (4 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Lung Cancer" (2 trials) and "Bone Metastasis" (1 trials). Many other conditions were trialed in "Veszprém Megyei Tüdőgyógyintézet" in a lesser frequency.
Clinical Trials Intervention Types at Veszprém Megyei Tüdőgyógyintézet
Most popular intervention types in "Veszprém Megyei Tüdőgyógyintézet" are "Drug" (23 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Carboplatin" (4 trials), "Pemetrexed" (3 trials), "Amivantamab" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Veszprém Megyei Tüdőgyógyintézet
The vast majority of trials in "Veszprém Megyei Tüdőgyógyintézet" are
24 trials for "All" genders.
Clinical Trials Status at Veszprém Megyei Tüdőgyógyintézet
Currently, there are NaN active trials in "Veszprém Megyei Tüdőgyógyintézet".
undefined are not yet recruiting,
3 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Veszprém Megyei Tüdőgyógyintézet,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Veszprém Megyei Tüdőgyógyintézet, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".